Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06560398 · ClinicalTrials.gov registry record · NA
Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)
A NA study of Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 7,649
- Enrollment target
- 1
- Study location
NCT06560398: Recruiting NA study of Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT06560398 is a NA study of Cancer that is actively recruiting participants, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 7,649 participants, above the 3,479-participant average among 615 other Cancer trials with a reported enrollment target (120% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06560398, a NA study of Cancer, is actively recruiting participants, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 7,649 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to refine, finalize, implement, and evaluate a multi-level intervention aimed at increasing enrollment of Black and Hispanic patients to National Cancer Institute (NCI)-sponsored therapeutic clinic trials at Moffitt Cancer Center.
Primary Outcome
Intervention impact on enrollment rates will be measured by comparing the percentage of Moffitt patients enrolled on NCI-supported treatment trials who are Black or Hispanic between intervention priority zones and the control priority zones.
Conditions Studied
Interventions
- BEHAVIORAL Continuing Medical Education Events (CME)
- BEHAVIORAL Trial Connect Portal
- BEHAVIORAL Clinical Trial Newsletters
- BEHAVIORAL Implicit Bias Training
- BEHAVIORAL Recruitment Dashboard
Study Locations (1)
Florida
- Moffitt Cancer Center - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,649 participants |
| Start Date | 2024-09-18 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
What NCT06560398 shows while recruiting
NCT06560398 is an interventional study that assigns participants to a tested intervention. Its 7,649 participants enrollment target places it among the larger protocols in the corpus, above the 3,479-participant average among 615 other Cancer trials with a reported enrollment target (120% higher).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 5 interventions - of which Continuing Medical Education Events (CME) is the first listed.
NCT06560398 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06560398 about?
NCT06560398 is a clinical study titled "Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)". The purpose of the study is to refine, finalize, implement, and evaluate a multi-level intervention aimed at increasing enrollment of Black and Hispanic patients to National Cancer Institute (NCI)-sponsored therapeutic clinic trials at Moffitt Cancer Center.
What is the current status of trial NCT06560398?
This trial is currently recruiting. It is a NA study. The enrollment target is 7,649 participants. The study started on 2024-09-18. Estimated completion is 2026-09-01.
What conditions does trial NCT06560398 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT06560398?
The interventions under investigation include: Continuing Medical Education Events (CME) (BEHAVIORAL), Trial Connect Portal (BEHAVIORAL), Clinical Trial Newsletters (BEHAVIORAL), Implicit Bias Training (BEHAVIORAL), Recruitment Dashboard (BEHAVIORAL).
Who is sponsoring clinical trial NCT06560398?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06560398 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06560398's enrollment target sits among peer trials
7,649 34th of 615 higher than 582 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03848312 · 7,600 participants · Phase 3
Preventing Alzheimer's With Cognitive Training
- NCT00439049 · 7,500 participants
Substance Abuse Pre-Treatment Screening Study
- NCT05199701 · 7,500 participants · NA
Prospective Case Collection Study for New Mammography Technologies
- NCT06112418 · 7,500 participants · NA
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI